Profile data is unavailable for this security.
About the company
Ossur hf is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The Company's main markets are North America, Europe and Asia. It has subsidiaries in Iceland, the United States, Canada, Mexico, France, the Netherlands, the United Kingdom, Sweden, Norway, Spain, South Africa, China and Australia.
- Revenue in DKK (TTM)4.95bn
- Net income in DKK293.11m
- Incorporated1971
- Employees3.87k
- LocationOssur hfGrjothals 5REYKJAVIK 110IcelandISL
- Phone+354 5151300
- Fax+354 5151366
- Websitehttps://www.ossur.com/
More ▼
Mergers & acquisitions
| Acquired company | OSSR:CPH since announced | Transaction value |
|---|---|---|
| RCM Enterprise LLC | 21.11% | -- |
Data delayed at least 15 minutes, as of Feb 03 2023 15:59 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellaVision AB | 426.10m | 82.31m | 4.01bn | 234.00 | 48.73 | 10.12 | 37.09 | 9.41 | 5.27 | 5.27 | 27.30 | 25.40 | 0.8102 | 1.72 | 7.64 | 3,255,925.00 | 15.65 | 18.72 | 18.52 | 22.72 | 69.28 | 70.70 | 19.32 | 21.74 | 1.85 | 14.75 | 0.1552 | 29.04 | 19.96 | 16.37 | 40.07 | 15.95 | 29.89 | 5.92 |
| Synsam AB (publ) | 3.37bn | 212.01m | 4.37bn | 3.25k | 20.60 | 2.61 | 7.03 | 1.30 | 2.16 | 2.16 | 34.33 | 17.02 | 0.6659 | 2.34 | 14.05 | -- | 4.20 | -- | 5.75 | -- | 76.35 | -- | 6.31 | -- | 0.5971 | 2.16 | 0.621 | -- | 22.67 | -- | 126.15 | -- | -- | -- |
| Xvivo Perfusion AB | 271.74m | 12.06m | 4.91bn | 118.00 | 408.13 | 5.30 | 123.92 | 18.08 | 0.6224 | 0.6224 | 14.02 | 47.94 | 0.2536 | 1.29 | 4.99 | -- | 1.13 | 0.0093 | 1.21 | 0.01 | 71.51 | 72.39 | 4.44 | 0.0371 | 2.68 | -- | 0.007 | 0.00 | 60.73 | 22.86 | 126.04 | 24.10 | -- | -- |
| BICO Group AB | 1.36bn | 26.70m | 5.36bn | 1.27k | 200.17 | 1.04 | 25.62 | 3.93 | 0.5923 | 0.5923 | 32.54 | 114.41 | 0.2372 | 0.9126 | 3.76 | 2,342,135.00 | 0.4586 | -- | 0.5044 | -- | 81.72 | -- | 1.93 | -- | 1.55 | -- | 0.2002 | -- | -- | -- | -- | -- | -- | -- |
| Arjo AB (publ) | 6.53bn | 292.49m | 7.04bn | 6.69k | 25.79 | 1.51 | 7.06 | 1.08 | 1.64 | 1.64 | 36.64 | 27.99 | 0.6484 | 3.79 | 6.14 | -- | 2.90 | 3.44 | 4.52 | 5.33 | 42.20 | 44.39 | 4.47 | 5.34 | 0.7369 | 7.51 | 0.453 | 42.64 | 10.02 | 5.35 | -39.76 | 30.52 | -- | 11.20 |
| Biotage AB | 997.22m | 156.39m | 7.59bn | 510.00 | 48.66 | 7.25 | 34.83 | 7.61 | 3.61 | 3.61 | 23.04 | 24.23 | 0.8002 | 2.30 | 7.02 | 3,066,399.00 | 12.55 | 14.87 | 15.33 | 17.80 | 61.29 | 61.37 | 15.68 | 17.18 | 1.75 | 11.60 | 0.1097 | 44.47 | 12.79 | 13.03 | 16.92 | 17.18 | 3.33 | 4.40 |
| Revenio Group Oyj | 688.33m | 160.93m | 7.98bn | 191.00 | 49.59 | 12.43 | 41.99 | 11.60 | 0.8106 | 0.8106 | 3.47 | 3.23 | 0.7678 | 7.20 | 8.33 | 502,597.80 | 17.87 | 16.31 | 21.17 | 19.98 | 50.96 | 51.88 | 23.27 | 22.28 | 1.78 | -- | 0.2054 | 69.84 | 29.00 | 27.44 | 29.63 | 24.25 | 9.80 | -14.40 |
| Ossur hf | 4.95bn | 293.11m | 14.97bn | 3.87k | 51.12 | 3.39 | 23.45 | 3.02 | 0.6921 | 0.6921 | 11.73 | 10.43 | 0.5588 | 2.36 | 6.68 | 1,281,617.00 | 3.36 | 4.81 | 4.03 | 5.61 | 61.19 | 62.74 | 6.01 | 7.89 | 0.9144 | 7.48 | 0.4308 | 7.19 | -0.0026 | 4.79 | -33.57 | -5.91 | 6.26 | -- |
| Elekta AB (publ) | 9.98bn | 540.49m | 18.87bn | 4.66k | 36.21 | 3.28 | 15.39 | 1.89 | 2.16 | 2.16 | 39.91 | 23.89 | 0.5972 | 3.40 | 2.84 | 3,209,640.00 | 3.25 | 4.84 | 5.99 | 8.86 | 37.12 | 41.03 | 5.44 | 8.88 | 0.7558 | 4.65 | 0.3847 | 55.05 | 5.70 | 6.33 | -7.97 | 55.98 | 12.71 | 19.14 |
| Ambu A/S | 4.44bn | 93.00m | 23.03bn | 4.41k | 277.43 | 6.15 | 59.98 | 5.18 | 0.3716 | 0.3716 | 17.53 | 16.77 | 0.6861 | 1.92 | 6.15 | 1,007,938.00 | 1.44 | 5.08 | 1.72 | 6.27 | 57.47 | 60.06 | 2.09 | 7.08 | 0.932 | -- | 0.3022 | 27.94 | 10.74 | 13.54 | -62.35 | -20.94 | 28.54 | -- |
| GN Store Nord A/S | 17.52bn | 670.00m | 26.03bn | 8.17k | 36.34 | 3.37 | 11.81 | 1.49 | 5.22 | 5.22 | 136.80 | 56.29 | 0.7187 | 3.06 | 4.89 | 2,423,492.00 | 2.95 | 9.04 | 4.38 | 12.20 | 51.42 | 58.31 | 4.11 | 11.12 | 0.5192 | 5.59 | 0.6911 | 33.63 | 17.29 | 12.77 | 40.26 | 10.09 | 14.20 | 6.15 |
| Getinge AB | 18.51bn | 1.63bn | 41.66bn | 11.11k | 27.39 | 2.27 | 14.77 | 2.25 | 9.15 | 9.15 | 103.87 | 110.28 | 0.5858 | 2.71 | 5.68 | -- | 5.21 | 3.97 | 6.54 | 5.18 | 47.40 | 47.99 | 8.90 | 6.56 | 1.57 | 25.03 | 0.1605 | 39.88 | 4.60 | 4.69 | -16.13 | 17.85 | -7.34 | 23.16 |
| Demant A/S | 18.66bn | 2.65bn | 50.41bn | 18.13k | 19.04 | 6.42 | -- | 2.70 | 11.49 | 10.37 | 81.12 | 34.06 | 0.7328 | 2.05 | 5.31 | 1,106,131.00 | 10.42 | 9.07 | 18.49 | 14.78 | 75.16 | 75.23 | 14.22 | 11.96 | 0.5879 | 45.49 | 0.6212 | 0.00 | 23.75 | 8.33 | 140.50 | 13.07 | 11.99 | -- |
Data as of Feb 03 2023. Currency figures normalised to Ossur hf's reporting currency: Danish Krone DKK
12.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SEB Investment Management ABas of 31 Dec 2022 | 17.16m | 4.06% |
| Invesco Advisers, Inc.as of 31 Dec 2022 | 8.26m | 1.95% |
| Lannebo Fonder ABas of 30 Jun 2022 | 8.09m | 1.91% |
| Handelsbanken Fonder ABas of 31 Jan 2023 | 5.74m | 1.36% |
| ODIN Forvaltning ASas of 31 Dec 2022 | 4.98m | 1.18% |
| Artisan Partners LPas of 30 Jun 2022 | 4.33m | 1.02% |
| Royce & Associates LPas of 30 Sep 2022 | 2.42m | 0.57% |
| Fondita Fund Management Co. Ltd.as of 31 Dec 2022 | 1.71m | 0.40% |
| Lazard Fr�res Gestion SASas of 30 Jun 2021 | 1.13m | 0.27% |
| Apo Asset Management GmbHas of 30 Dec 2022 | 1.02m | 0.24% |
More ▼
Data from 30 Sep 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
